Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.37 -0.01 (-0.30%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.45 +0.08 (+2.37%) 16:41 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.26
Day High
3.46
Open 3.35
Previous Close 3.38 3.38
Volume 618,700 618,700
Avg Vol 376,295 376,295
Stochastic %K 8.10% 8.10%
Weighted Alpha -66.96 -66.96
5-Day Change -0.35 (-9.41%) -0.35 (-9.41%)
52-Week Range 3.26 - 10.31 3.26 - 10.31
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 186,600
  • Shares Outstanding, K 55,207
  • Annual Sales, $ 80,000 K
  • Annual Income, $ -65,000 K
  • EBIT $ -83 M
  • EBITDA $ -87 M
  • 60-Month Beta 0.99
  • Price/Sales 2.52
  • Price/Cash Flow N/A
  • Price/Book 0.67

Options Overview Details

View History
  • Implied Volatility 244.16% ( +80.78%)
  • Historical Volatility 46.58%
  • IV Percentile 98%
  • IV Rank 56.97%
  • IV High 394.63% on 02/21/25
  • IV Low 44.91% on 09/05/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 6
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 2,829
  • Open Int (30-Day) 3,019

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.35
  • Number of Estimates 5
  • High Estimate -0.17
  • Low Estimate -0.55
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.26 +3.37%
on 04/01/25
Period Open: 4.08
4.32 -21.99%
on 03/13/25
-0.71 (-17.40%)
since 02/28/25
3-Month
3.26 +3.37%
on 04/01/25
Period Open: 5.67
6.27 -46.25%
on 01/07/25
-2.30 (-40.56%)
since 12/31/24
52-Week
3.26 +3.37%
on 04/01/25
Period Open: 10.54
10.31 -67.31%
on 04/02/24
-7.17 (-68.03%)
since 04/01/24

Most Recent Stories

More News
Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PDâ„¢ 2025

VYGR : 3.37 (-0.30%)
Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics: Q4 Earnings Snapshot

VYGR : 3.37 (-0.30%)
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

VYGR : 3.37 (-0.30%)
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

VYGR : 3.37 (-0.30%)
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease

VYGR : 3.37 (-0.30%)
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR : 3.37 (-0.30%)
Voyager Provides Update on SOD1 ALS Gene Therapy Program

VYGR : 3.37 (-0.30%)
Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference

VYGR : 3.37 (-0.30%)
Axsome Shares Rise 19% in a Month: What's Driving the Rally?

Axsome Therapeutics’ AXSM shares have rallied 19.4% in the past month against the industry’s decrease of 0.2%, driven by investor enthusiasm about the company’s encouraging preliminary sales numbers...

JAZZ : 124.99 (+0.68%)
VYGR : 3.37 (-0.30%)
CSTL : 19.78 (-1.20%)
AXSM : 111.67 (-4.25%)
Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

Beam Therapeutics BEAM is developing its lead pipeline candidate, BEAM-101, a base-editing therapy, in the phase I/II BEACON study for treating sickle cell disease (SCD), an inherited blood disorder.BEAM’s...

BEAM : 17.64 (-9.70%)
VYGR : 3.37 (-0.30%)
CSTL : 19.78 (-1.20%)
HRMY : 32.42 (-2.32%)

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 3.67
2nd Resistance Point 3.56
1st Resistance Point 3.47
Last Price 3.37
1st Support Level 3.27
2nd Support Level 3.16
3rd Support Level 3.07

See More

52-Week High 10.31
Fibonacci 61.8% 7.62
Fibonacci 50% 6.79
Fibonacci 38.2% 5.95
Last Price 3.37
52-Week Low 3.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies